Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
LB Pharmaceuticals eyes $228M in IPO cash
The CNS-focused company is looking to pull off the first biotech IPO since February and collect $228.5 million in much-needed funding.
Zoey Becker
Sep 8, 2025 3:16pm
BioNTech, BMS tout first global data for PD-L1xVEGF drug in SCLC
Sep 8, 2025 11:00am
FDA rejects another ultra-rare disease prospect
Sep 8, 2025 10:59am
FDA clears Microbot’s remote-controlled cath lab system
Sep 8, 2025 11:45am
Regeneron antibodies post ph. 3 wins against cat, pollen allergy
Sep 8, 2025 9:54am
Dianthus' gMG asset blooms as phase 2 win sets up pivotal plans
Sep 8, 2025 9:24am
More News
Atom claims ph. 3 win shows gout drug can beat competition
Sep 8, 2025 9:01am
Rapport's seizure drug hits in phase 2, sending stock soaring
Sep 8, 2025 8:25am
Fierce Biotech Fundraising Tracker: NRG Tx, Epigenic & more
Sep 8, 2025 8:20am
Takeda, Alkermes lift lid on narcolepsy rivals as race heats up
Sep 8, 2025 6:47am
See more stories